DocWire News Editors

DocwireNews

The National Asthma Education and Prevention Program was established in 1989 to address increasing asthma mortality and morbidity. The group recommends that the National Heart, Lung, and Blood Institute (NHLBI) partner with medical societies to create clinical guidelines. Recently, NHLBI formed a working group to consider updates to the latest Expert Panel Report, and identified the following topics for review:<ul>
<li>Clinical utility of fractional exhaled nitric oxide in asthma management</li>
<li>Immunotherapy in treatment of asthma</li>
<li>Intermittent inhaled corticosteroids and long-acting muscarinic antagonists for asthma</li>
<li>Effectiveness and safety of bronchial thermoplasty management of asthma</li>
<li>Effectiveness of indoor allergen reduction in management of asthma</li>
</ul>The University of Pennsylvania (UPenn) was contracted to take on the last topic. During a session at the 2018 AAAAI Annual Meeting,&nbsp;Andrea J. Apter, MD, MA, MSc,&nbsp;and&nbsp;Brian F. Leas, MS, MA,&nbsp;both of UPenn, discussed this research project.&ldquo;We conducted a systematic review to help the panel writing that guideline,&rdquo; Dr. Leas said, noting that they are not sure of its status and do not know what the panel&rsquo;s ultimate recommendations will be. &ldquo;But it&rsquo;s important to discuss what we found and how we interpreted the findings,&rdquo; he said.Their review focused on six allergens: animal dander, cockroaches, house dust mites, household pets, mold, and rodents; other allergen and irritants were excluded. They examined eight interventions: acaricide, air purification, carpet removal, carpet cleaning, pillow and mattress covers, mold removal, pest control, and pet removal, with articles focusing on both single- and multi-component interventions.The study population included both adults and children; &ge;85% had an asthma diagnosis, any disease severity was allowed, and they looked at home-, school-, and work-related allergens. Case series and reports, as well as risk-association studies were excluded, and they only used interventional studies. &ldquo;We looked for best available research,&rdquo; Dr. Leas said of their parameters.The primary outcomes of the included studies were validated measures of control, asthma exacerbations, asthma-related healthcare utilization and costs, pulmonary physiology, and quality of life. A secondary outcome was allergen reduction.They narrowed the study pool to 59 randomized, controlled trials (RCTs) and eight observational studies. The researchers focused more on the RCTs when analyzing outcomes: 25 were multi-component studies, 17 studies looked at single intervention mattress covers, and nine looked at single intervention air purifiers. The studies were diverse in terms of age cohorts and were conducted worldwide. Dr. Leas noted that the NHLBI will need to consider how relevant some of these studies are when writing the guidance, however.Identifying statistically significant interventions and combinations of interventions was difficult, Dr. Leas said. &ldquo;We can&rsquo;t say, &lsquo;These two things are&nbsp;always&nbsp;included in [positive] studies,&rsquo;&rdquo; he noted. They did find statistically significant improvements mostly in the areas of symptom and allergen reductions, but it is unknown if these were clinically significant.Dr. Apter discussed highlights of the findings, including:<ul>
<li>Single interventions were not generally associated with improvement in asthma measures</li>
<li>Multi-component interventions improved various outcomes, but no combination of specific interventions appeared to be more effective than another</li>
<li>No high strength evidence suggests improvement in any of the primary outcomes</li>
<li>Evidence was often inconclusive due to lack of studies</li>
<li>Validated measures of asthma control were infrequently reported</li>
<li>Other standardized measure, such as exacerbations, healthcare utilization, and quality of life, were infrequently reported.</li>
</ul>&ldquo;This is a roadmap to what the next steps may be to develop more useful guidelines moving forward,&rdquo; Dr. Leas concluded.Drs. Apter and Leas noted some limitations of their work, including a high degree of heterogeneity and variation in asthma severity among studies; home-based interventions are difficult to implement for various reasons, including cost, language, technology, home ownership, and health literacy; adherence to protocols is difficult; and attrition rates were high in some studies.The ultimate goal is to establish a guideline that will improve asthma outcomes, Dr. Apter said.Presentation 3705: HEDQ: Asthma Guidelines for Indoor Allergen Interventions: Methods and Clinical Implications

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

HER2 Breast Cancer

Trodelvy Plus Keytruda Significantly Improves Progression-Free Survival in PD-L1+ mTNBC, Phase III Data Show

Triple-Negative Breast Cancer

Jordana Jampel

Actress Michelle Trachtenberg's Premature Death From Diabetes Reveals Dangers of Chronic Complications

Diabetes

Latest News

Study of Indoor Allergen Reduction for Asthma Management: How Will this Impact Future Guidelines?

AAAAI 2018

The National Asthma Education and Prevention Program was established in 1989 to address increasing asthma mortality and morbidity. The group recommends that the National ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe